These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 1347913)

  • 41. Inhibition of thyroid hormone action by a non-hormone binding c-erbA protein generated by alternative mRNA splicing.
    Koenig RJ; Lazar MA; Hodin RA; Brent GA; Larsen PR; Chin WW; Moore DD
    Nature; 1989 Feb; 337(6208):659-61. PubMed ID: 2537467
    [TBL] [Abstract][Full Text] [Related]  

  • 42. GAR22: a novel target gene of thyroid hormone receptor causes growth inhibition in human erythroid cells.
    Gamper I; Koh KR; Ruau D; Ullrich K; Bartunkova J; Piroth D; Hacker C; Bartunek P; Zenke M
    Exp Hematol; 2009 May; 37(5):539-548.e4. PubMed ID: 19375645
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thyroid hormone receptor/c-erbA: control of commitment and differentiation in the neuronal/chromaffin progenitor line PC12.
    Muñoz A; Wrighton C; Seliger B; Bernal J; Beug H
    J Cell Biol; 1993 Apr; 121(2):423-38. PubMed ID: 8385673
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Requirements for repression of retinoid X receptor by the oncoprotein P75gag-v-erbA and the thyroid hormone receptors.
    Wahlström GM; Vennström B
    Mol Endocrinol; 1998 May; 12(5):645-53. PubMed ID: 9605927
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thyroid hormone receptor/and v-erbA. A single amino acid difference in the C-terminal region influences dominant negative activity and receptor dimer formation.
    Selmi S; Samuels HH
    J Biol Chem; 1991 Jun; 266(18):11589-93. PubMed ID: 1675637
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The zebrafish thyroid hormone receptor alpha 1 is expressed during early embryogenesis and can function in transcriptional repression.
    Essner JJ; Breuer JJ; Essner RD; Fahrenkrug SC; Hackett PB
    Differentiation; 1997 Dec; 62(3):107-17. PubMed ID: 9447705
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phosphorylation of the v-erbA protein is required for its function as an oncogene.
    Glineur C; Zenke M; Beug H; Ghysdael J
    Genes Dev; 1990 Oct; 4(10):1663-76. PubMed ID: 1979040
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Roles of v-erbA homodimers and heterodimers in mediating dominant negative activity by v-erbA.
    Yen PM; Ikeda M; Brubaker JH; Forgione M; Sugawara A; Chin WW
    J Biol Chem; 1994 Jan; 269(2):903-9. PubMed ID: 7904604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. v-erbA acts on retinoic acid receptors in immature avian erythroid cells.
    Sande S; Sharif M; Chen H; Privalsky M
    J Virol; 1993 Feb; 67(2):1067-74. PubMed ID: 8093487
    [TBL] [Abstract][Full Text] [Related]  

  • 50. v-erbA oncogene induces invasiveness and anchorage-independent growth in cultured glial cells by mechanisms involving platelet-derived growth factor.
    Llanos S; Iglesias T; Riese HH; Garrido T; Caelles C; Muñoz A
    Cell Growth Differ; 1996 Mar; 7(3):373-82. PubMed ID: 8838867
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha.
    Damm K; Evans RM
    Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10668-72. PubMed ID: 7902566
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increase in proto-oncogene raf expression precedes differentiation induction in different clonal rhabdomyosarcoma subpopulations.
    Ramp U; Gerharz CD; Doehmer J; Oster O; Gabbert HE
    Anticancer Res; 1992; 12(2):537-46. PubMed ID: 1316093
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The lack of transcriptional activation of the v-erbA oncogene is in part due to a mutation present in the DNA binding domain of the protein.
    de Verneuil H; Metzger D
    Nucleic Acids Res; 1990 Aug; 18(15):4489-97. PubMed ID: 1975094
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A hepatitis B virus pre-S-retinoic acid receptor beta chimera transforms erythrocytic progenitor cells in vitro.
    Garcia M; de Thé H; Tiollais P; Samarut J; Dejean A
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):89-93. PubMed ID: 8093562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional inhibition of retinoic acid response by dominant negative retinoic acid receptor mutants.
    Damm K; Heyman RA; Umesono K; Evans RM
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2989-93. PubMed ID: 8096643
    [TBL] [Abstract][Full Text] [Related]  

  • 56. v-erbA oncogene function in neoplasia correlates with its ability to repress retinoic acid receptor action.
    Sharif M; Privalsky ML
    Cell; 1991 Sep; 66(5):885-93. PubMed ID: 1679679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of protein kinase C or cAMP-dependent protein kinase increases phosphorylation of the c-erbA-encoded thyroid hormone receptor and of the v-erbA-encoded protein.
    Goldberg Y; Glineur C; Gesquière JC; Ricouart A; Sap J; Vennström B; Ghysdael J
    EMBO J; 1988 Aug; 7(8):2425-33. PubMed ID: 2903825
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isolation of a cDNA encoding human Rev-ErbA alpha: transcription from the noncoding DNA strand of a thyroid hormone receptor gene results in a related protein that does not bind thyroid hormone.
    Lazar MA; Jones KE; Chin WW
    DNA Cell Biol; 1990 Mar; 9(2):77-83. PubMed ID: 1971514
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alteration of a single amino acid residue in retinoic acid receptor causes dominant-negative phenotype.
    Saitou M; Narumiya S; Kakizuka A
    J Biol Chem; 1994 Jul; 269(29):19101-7. PubMed ID: 7913468
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel cis element mediating ligand-independent activation by c-ErbA: implications for hormonal regulation.
    Saatcioglu F; Deng T; Karin M
    Cell; 1993 Dec; 75(6):1095-105. PubMed ID: 7903219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.